TCTR20210527003Enrolling By Invitation2 期
The impact of portal flow modulation for prevention post hepatectomy liver failure by splenic artery ligation: A randomized controlled trial
Faculty of Medicine CM0 个研究点目标入组 72 人开始时间: 2021年5月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Patient who underwent hepatectomy (at least 2 segments) with and without bile duct resection
- •Hepatocellular carcinoma
- •Cholangiocarcinoma
- •Colorectal liver metastasis
- •Benign liver tumor
- •Cystic tumor of liver
- •Liver abscess
- •2. open hepatectomy
- •3. Age 20-70 year
- •4. accept to join this program
排除标准
- •Patients who is unresectable by surgical technique reason
- •Metastasis liver disease
- •High risk for surgery
研究者
相似试验
招募中
Unknown
The impact of portal vein major circulation short-circuit embolization on the clinical course of the disease.diffuse liver diseaseJPRN-UMIN000052853Chiba University1,000
已完成
不适用
Splenic Artery Ligation and Portocaval Shunt in Small-for-size SyndromeSmall-For-Size Liver SyndromeLigationLiver RegenerationSplenic ArteryPortal VeinIschemiaReperfusion InjuryHepatectomyNCT05459883Aretaieion University Hospital13
招募中
不适用
Clinical trial to study the effect of modulating blood flow to liver graft in cases of portal hyperperfusion in living donor liver transplantatioCTRI/2020/02/023273Institute of Liver and Biliary Sciences
尚未招募
不适用
The effect of portal vein embolisation on portal venous perfusion of the liverPrimary or secondary liver tumor.10019654NL-OMON34722Academisch Medisch Centrum45
已完成
不适用
Surrogate Markers of Portal PressurePortal HypertensionCirrhosisNCT02508298VA Connecticut Healthcare System41